ZnO Nanoparticles and Rifampicin Synergistically Damage the Membrane of Mycobacteria

Abstract

The emergence of drug resistance in tuberculosis requires alternative strategies to combat the resistance. To this end, we have synthesized zinc oxide nanoparticles (ZnO NPs) of 11 nm diameter and evaluated its effect against mycobacteria alone, as well as in combination with the first-line anti-TB drug, rifampicin. These ZnO NPs themselves are not inhibitory against the wild-type (WT) Mycobacterium smegmatis, up to a concentration as high as 256 μg/mL. However, a subinhibitory concentration of only 32 μg/mL of ZnO NPs in combination with rifampicin, showed a 4-fold reduction in the minimum inhibitory concentration of rifampicin, against WT M. smegmatis. Thus, the fractional inhibitory concentration index for the combination was found to be 0.375, which proves the effect to be synergistic. This is explained by high membrane permeability observed in presence of the combination of ZnO NPs and rifampicin, which increased with time. High membrane permeability, in turn, increased rifampicin uptake in cells, which subsequently enhanced the bactericidal effect of the drug. The resultant morphology of the bacteria, from Cryo-SEM, showed membrane damage, following treatment with a combination of ZnO NPs and rifampicin. However, this combination showed very less reactive oxygen species (ROS) production, compared to ZnO NPs alone. Hence, we can conclude that membrane damage is the dominant mechanism behind synergism of the combination, rather than that of ROS generation. This combination also proved to be successful against our laboratory-generated, drug resistant strains of M. smegmatis, as well as against vaccine strain- M. bovis BCG, which proves the general applicability of this synergism for different strains. We hence propose that our developed ZnO NPs and drug combination can be promising for overcoming mycobacterial drug resistance.

Breaking barriers: The potential of nanosystems in antituberculosis therapy

“…Mistry et al [ 318 ] studied the synergistic action of ZnO NPs and RIF against Mycobacteriym smegmatis , a non-virulent strain like MTB. The ZnO NPs were synthesized through precipitation in organic media, using zinc acetate dihydrate and sodium hydroxide in methanol.…”

Synthesis and Antimicrobial Applications of ZnO Nanostructures: A Review

“…coli) confirmed that hybrid PDA@ZnO NPs on the functionalized surface provided an effective antibacterial effect by means of three potential pathways: (a) ROS damage the intracellular contents, including proteins, DNA, ATP, etc., through intense oxidative stress reactions after being internalized into the bacterial cell membrane; (b) zinc ions released from the ZnO nanoparticles can cause mechanical damage to the bacterial cell wall, thus penetrating cell membranes to inhibit active transport and glucose metabolism and disrupt metal ion homeostasis and enzyme systems when the concentration reaches a specific level; (c) ZnO nanoparticles directly contact bacterial cell walls, causing damage to the membrane integrity and subsequent death . Interestingly, ZnO NPs were coupled with antibiotics to exhibit synergistic efficacy and support the antibiotic resistance fight. − Finally, antibacterial ZnO NP-based materials were widely proposed for water purification, acting as both photocatalysts and antibacterial agents. ,,, …”

Nanosized Drug Delivery Systems to Fight Tuberculosis

“…For instance, INH-loaded selenium NPs favor Mtb localization within lysosomes [ 112 ]. Similarly, RFP-loaded ZnO NPs cause irreversible damage to the membrane of Mycobacterium smegmatis (a surrogate of Mtb ) and are also effective against resistant strains of Mycobacterium bovis [ 132 ].…”